Optibiotix Health Share Discussion Threads

[jamesrs1] 08/2/2019 07:02

Rome wasn’t built in one day.
It’s just a matter of time before this is over £1 again.

[rayrac] 08/2/2019 00:00

Seen that list before...it means nothing, just agreements, not income bearing contracts.

[parob] 07/2/2019 18:18

Updated list:Recent, current and potential future revenue streams confirmed:- GoFigure: shakes, bars and muesli pots - CholBiome (x3 and Daily Maintenance)- Sacco/CSL - HLH BioPharma Vertriebs GmbH - Nutrilinia (LD-LDL and Slimbiome Medical)- Pharmabiota- Galenicum Special Ingredients - Knighton Foods- Cereal Ingredients Inc.- Fine Foods & Pharmaceuticals- Trigen Pharma- Cambridge Commodities - Akums Drugs and Pharma- Seed Health- John Morley's - Alfasigma- Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution.- Unnamed US pharma partner (cholesterol strain)- Bened Biomedical- Bulgarian CholBiome distributor (Velinoff Pharma)- CTC Group- Formulation Creations- US Pharma Lab Inc.- Unnamed Greece and Cyprus CholBiome distributor- Unnamed Greece and Cyprus SlimBiome Medical distributor - Zeon Lifesciences - SilvExpo - CholBiome- Biolat - RMS CardioProRevenue not confirmed yet:- Tata X 2 (Slimbiome and LPGOS)- Mystery US Slimbiome customer- Paradise Fruits (Slimbiome)- Beijing Duoite Biotechnology Co., Ltd (LP-LDL distributors via CSL)Products on the market already but not RNSed:- MuscleForm (Aviform Ltd) - Ultra MR Ultimate Meal Replacement - Olliscience - Ollibiotic - Aragan - Biotic•P3- 39ytu - Capsa Food

[incanus] 07/2/2019 15:51

There a couple of clues about the picture in elrico's latest update today.

[nobbygnome] 07/2/2019 15:16

So immediate revenues contrary to whoever said said this morning that it would take a year. Sometimes I despair of the negativity and cynicism😏....

[rayrac] 07/2/2019 14:56

I know a private company in biotech that pulls in €10m from Romania alone so just because you have not heard of the company shouldn’t mean automatically underestimating their reach.

Name the company and the product/s it sells to Romania, risky! ;))

It’s all smoke and mirrors, but no cash in sight.

[incanus] 07/2/2019 14:25

That last para made me laugh. Who posted the picture and where? Has it been taken down. I would have paid good money to see the managements faces when they seen the picture.

Funny.

[trotterstrading] 07/2/2019 12:19

This is undoubtedly the best and most sustainable business model but the early part of the cycle takes time to build critical mass. Keep the faith our patience will be richly rewarded. FYI - for those in doubt today's announcement should contribute revenues immediately, I got this from Per this morning: "i did not write the RNS this time trying to get Luis involved to ease the burden on SOH when I'm gone.It's very simple we deliver them a finished product, a food supplement that they will sell under their brand.You guys have already posted pictures of the product (RSM CARDIO) before we had and agreement and we had to ask them to take it of the internet until we had the agreement."

[judijudi] 07/2/2019 12:05

risky,
The BB leader is playing his normal game
So transparent, but funny
:)

[riskybusiness1] 07/2/2019 11:38

Not particularly unless you want to drastically overhaul the low cost model. These companies may not be heard of by PIs but they are fast growing established companies in their respected markets. Why on earth would you not sell to them if they want the product. You do realise Opti are not specifically targeting Latvia to sell the products but are clearly getting contacted by a vast range of companies. It's not like Pers set off to Latvia to sign these deals....There is a mix of small, medium and large partners which will accumulate in to significant profits whilst increasing the global brand at zero cost. I know a private company in biotech that pulls in €10m from Romania alone so just because you have not heard of the company shouldn't mean automatically underestimating their reach.

[someuwin] 07/2/2019 11:09

Is doing multiple piecemeal deals with unheard of companies for small territories really the most efficient way of rolling the products out?

Surely there must be a better way?

[riskybusiness1] 07/2/2019 11:02

Possibly? Like they've written into a three year contract that they will 'possibly' sell the product. Seriously In the mean time existing deals are producing revenues, launching new products and more deals are piling on top. In any business the above combined with low cost model tends to be successful in virtually all cases.

[rathean] 07/2/2019 10:46

More cheddar tomorrow... possibly. Still lacking any visibility over near term earnings, always just 12 months away from justifying it's potential and sky high valuation imo dyor ofc.

[imnotlong] 07/2/2019 09:07

By the way Diamond, well done on your ‘guaranteed news’ prediction for this week. I’ve never doubted you with your ‘down the pub’ method of getting insight into what’s happening at Opti.

[someuwin] 07/2/2019 09:01

'Chilbiome' would be a great product - One that a few on this board could do with.

[aspex] 07/2/2019 08:54

Maybe but why introduce unnecessary complexity for minimal extra margin (?) when it is a shared agreement.Imagination is so wonderful.

[imnotlong] 07/2/2019 08:46

I think if revenues were expected soon the RNS would have stated that. So I will stick to my view of revenues being some time away.

[shrewdmole] 07/2/2019 08:40

Notlong

Sounds like they just rebadge chilbiome to me so a lot sooner to market!

[rayrac] 07/2/2019 08:26

As long as it doesn’t get put into expensive pots!

[imnotlong] 07/2/2019 07:53

Maybe 12 months before the income stream starts if Biolat have to develop the new product first.

[dire cons] 07/2/2019 07:46

Red thumb for a rns. LOL!

[nobbygnome] 07/2/2019 07:39

More money to the bottom line. Yes maybe not a vast amount but the drip drip of deals all adds up!